A pilot study of the association of amino-terminal pro-B-type natriuretic peptide and severity of illness in pediatric septic shock
Pediatric Critical Care Medicine Feb 11, 2019
Melendez E, et al. - Via this prospective observational pilot study enrolling children 0–17 years old with a diagnosis of septic shock, researchers assessed if Emergency Department amino-terminal pro-B-type natriuretic peptide is associated with worse outcomes and severity of illness. In participants, each decile change increase in amino-terminal pro-B-type natriuretic peptide was noted to be associated with a change in ICU length of stay by 8.7%, hospital length of stay by 5.7%, organ dysfunction by 5.1%, a higher inotropic score at 12, 24, and 36 hours, and longer time requiring vasoactive agents. A significant correlation was identified between baseline amino-terminal pro-B-type natriuretic peptide and the Pediatric RISk of Mortality 3 score.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries